Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer

Date Issued
2010-01-01
Author(s)
Hostettler, I
Muraro, M G
Mele, V
Carafa, V
DOI
10.1038/sj.bjc.6605762
Abstract
The aim of this study was to elucidate the prognostic impact of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and aldehyde dehydrogenase-1 (ALDH1) in colorectal cancer.
File(s)
Loading...
Thumbnail Image
Name

6605762.pdf

Size

1.06 MB

Format

Adobe PDF

Checksum

(MD5):0f0d4fd3d8ca258792c15f455e8d7ff0